Maralee McVean

613 total citations
16 papers, 479 citations indexed

About

Maralee McVean is a scholar working on Molecular Biology, Surgery and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Maralee McVean has authored 16 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Surgery and 3 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Maralee McVean's work include Effects and risks of endocrine disrupting chemicals (3 papers), Pancreatic function and diabetes (3 papers) and Chromatin Remodeling and Cancer (2 papers). Maralee McVean is often cited by papers focused on Effects and risks of endocrine disrupting chemicals (3 papers), Pancreatic function and diabetes (3 papers) and Chromatin Remodeling and Cancer (2 papers). Maralee McVean collaborates with scholars based in United States, Netherlands and Denmark. Maralee McVean's co-authors include D.C. Liebler, Jill C. Pelling, Hengyi Xiao, Ken‐ichi Isobe, Wendy C. Weinberg, Shawn P. Iadonato, Søren R. Paludan, Helle Kristiansen, Friedemann Weber and Rune Hartmann and has published in prestigious journals such as PLoS ONE, Cancer Research and Journal of Virology.

In The Last Decade

Maralee McVean

16 papers receiving 457 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maralee McVean United States 9 209 150 106 66 56 16 479
Bianca Altrão Ratti Brazil 11 194 0.9× 46 0.3× 49 0.5× 31 0.5× 51 0.9× 18 454
Mayumi Kotani Japan 9 139 0.7× 172 1.1× 73 0.7× 164 2.5× 55 1.0× 13 605
Sébastien Holvöet Switzerland 12 174 0.8× 82 0.5× 66 0.6× 152 2.3× 22 0.4× 20 698
Kyu‐Shik Lee South Korea 14 222 1.1× 42 0.3× 29 0.3× 51 0.8× 38 0.7× 44 536
Mi Sook Jeong South Korea 16 147 0.7× 221 1.5× 39 0.4× 88 1.3× 25 0.4× 18 519
Ah Ra Goh South Korea 11 169 0.8× 103 0.7× 32 0.3× 104 1.6× 26 0.5× 12 415
Sungchae Hong South Korea 11 178 0.9× 19 0.1× 38 0.4× 46 0.7× 49 0.9× 20 440
Ikuyo Sakaguchi Japan 12 130 0.6× 51 0.3× 37 0.3× 96 1.5× 16 0.3× 17 406
Joanna Wieczfińska Poland 14 198 0.9× 33 0.2× 44 0.4× 63 1.0× 28 0.5× 35 503
Melkamu Getie Germany 9 121 0.6× 54 0.4× 31 0.3× 16 0.2× 25 0.4× 10 500

Countries citing papers authored by Maralee McVean

Since Specialization
Citations

This map shows the geographic impact of Maralee McVean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maralee McVean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maralee McVean more than expected).

Fields of papers citing papers by Maralee McVean

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maralee McVean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maralee McVean. The network helps show where Maralee McVean may publish in the future.

Co-authorship network of co-authors of Maralee McVean

This figure shows the co-authorship network connecting the top 25 collaborators of Maralee McVean. A scholar is included among the top collaborators of Maralee McVean based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maralee McVean. Maralee McVean is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Lee, Janice Y., Nathan A. Brooks, Brandon Antonakos, et al.. (2024). Abstract 3230: Discovery of selective BRM (SMARCA2) ATPase inhibitors for the treatment of BRG1 (SMARCA4) mutant cancers. Cancer Research. 84(6_Supplement). 3230–3230. 1 indexed citations
2.
Lee, Janice Y., Nathan A. Brooks, Brandon Antonakos, et al.. (2024). Abstract PR015: Discovery of LY4050784 (FHD-909), a selective BRM (SMARCA2) ATPase inhibitor for the treatment of BRG1(SMARCA4) mutant cancers. Molecular Cancer Therapeutics. 23(6_Supplement). PR015–PR015. 1 indexed citations
3.
Morford, LaRonda L., et al.. (2022). Juvenile Bone Toxicity: Study Considerations, Regulations, and Techniques for Assessment. International Journal of Toxicology. 42(2). 182–197. 1 indexed citations
4.
Morton, Laura Dill, et al.. (2019). Confounding Factors in the Interpretation of Preclinical Studies. International Journal of Toxicology. 38(3). 228–234. 5 indexed citations
5.
Hobson, David W., JoAnn C. L. Schuh, Daniel V. Zurawski, et al.. (2016). The First Cut Is the Deepest. International Journal of Toxicology. 35(5). 491–498. 8 indexed citations
6.
Trounson, Alan, Kyle L. Kolaja, Thomas Petersen, et al.. (2015). Stem Cell Research. International Journal of Toxicology. 34(4). 349–351. 3 indexed citations
7.
Lü, Min, Pingping Li, Gautam Bandyopadhyay, et al.. (2014). Characterization of a Novel Glucokinase Activator in Rat and Mouse Models. PLoS ONE. 9(2). e88431–e88431. 16 indexed citations
8.
Hinklin, Ronald J., Thomas D. Aicher, Deborah Anderson, et al.. (2014). Discovery of 2-Pyridylureas as Glucokinase Activators. Journal of Medicinal Chemistry. 57(19). 8180–8186. 17 indexed citations
9.
Aicher, Thomas D., Steven A. Boyd, Maralee McVean, & Anthony Celeste. (2010). Novel therapeutics and targets for the treatment of diabetes. Expert Review of Clinical Pharmacology. 3(2). 209–229. 16 indexed citations
10.
Kristiansen, Helle, Christina Scherer, Maralee McVean, et al.. (2010). Extracellular 2′-5′ Oligoadenylate Synthetase Stimulates RNase L-Independent Antiviral Activity: a Novel Mechanism of Virus-Induced Innate Immunity. Journal of Virology. 84(22). 11898–11904. 85 indexed citations
11.
Shiraishi, Yoshiki, Yoo Seob Shin, Laurence E. Burgess, et al.. (2010). Potent and Selective CRTH2 Antagonists are Efficacious in Models of Asthma, Allergic Rhinitis (AR) and Atopic Dermatitis (AD). Journal of Allergy and Clinical Immunology. 125(2). AB124–AB124. 3 indexed citations
12.
McVean, Maralee, Wendy C. Weinberg, & Jill C. Pelling. (2002). A p21waf1‐independent pathway for inhibitory phosphorylation of cyclin‐dependent kinase p34cdc2 and concomitant G2/M arrest by the chemopreventive flavonoid apigenin. Molecular Carcinogenesis. 33(1). 36–43. 38 indexed citations
13.
Burns, Mark R., Maralee McVean, Bruce H. Devens, et al.. (2002). Induction of apoptosis by aryl-substituted diamines: role of aromatic group substituents and distance between nitrogens. Bioorganic & Medicinal Chemistry Letters. 12(9). 1263–1267. 17 indexed citations
14.
McVean, Maralee, Hengyi Xiao, Ken‐ichi Isobe, & Jill C. Pelling. (2000). Increase in wild-type p53 stability and transactivational activity by the chemopreventive agent apigenin in keratinocytes. Carcinogenesis. 21(4). 633–639. 94 indexed citations
15.
McVean, Maralee & D.C. Liebler. (1999). Prevention of DNA photodamage by vitamin E compounds and sunscreens: Roles of ultraviolet absorbance and cellular uptake. Molecular Carcinogenesis. 24(3). 169–176. 80 indexed citations
16.
McVean, Maralee. (1997). Inhibition of UVB induced DNA photodamage in mouse epidermis by topically applied alpha-tocopherol. Carcinogenesis. 18(8). 1617–1622. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bianca Altrão Ratti Breakdown of academic impact, for papers by Mayumi Kotani Breakdown of academic impact, for papers by Sébastien Holvöet Breakdown of academic impact, for papers by Kyu‐Shik Lee Breakdown of academic impact, for papers by Mi Sook Jeong Breakdown of academic impact, for papers by Ah Ra Goh Breakdown of academic impact, for papers by Sungchae Hong Breakdown of academic impact, for papers by Ikuyo Sakaguchi Breakdown of academic impact, for papers by Joanna Wieczfińska Breakdown of academic impact, for papers by Melkamu Getie
Rankless by CCL
2026